ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in LNTH — Lantheus Holdings, Inc.

CIK 1165408 Boston, MA

Back to LNTH Full portfolio

Position in LNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$27,374,999

+$1,073,633 QoQ

Shares Held

246,755

-28.8% QoQ

Ownership

0.378%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#53

of 466 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $373,675,487 across 10 Drug Manufacturers - Specialty & Generic names. LNTH ranks #6 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	6,050,771	$96,993,859
2	TEVA	Teva Pharmaceutical Industries Ltd	2,360,728	$79,981,464
3	ALKS	Alkermes plc.	1,368,000	$71,683,200
4	ELAN	Elanco Animal Health Inc	1,456,569	$35,846,163
5	AMLX	Amylyx Pharmaceuticals, Inc.	1,900,000	$34,124,000
6	LNTH	Lantheus Holdings, Inc. This page	246,755	$27,374,999
7	VTRS	Viatris Inc	843,736	$13,398,527
8	BIOA	BioAge Labs, Inc.	300,000	$7,353,000

All Filings in LNTH

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,374,999	246,755	-28.8%	Shares	Sole	2026-08-14
2026-03-31	$26,301,366	346,755	+54.1%	Shares	Sole	2026-05-15
2023-09-30	$15,633,000	225,000	+1025.0%	Shares	Sole	2023-11-14
2023-06-30	$1,678,400	20,000	-86.7%	Shares	Other	2023-08-14
2022-09-30	$10,549,500	150,000	-33.3%	Shares	Sole	2022-11-14
2022-06-30	$14,856,750	225,000	-55.0%	Shares	Sole	2022-08-15
2022-03-31	$27,655,000	500,000	+11.1%	Shares	Sole	2022-05-16
2021-12-31	$13,000,500	450,000	-10.0%	Shares	Sole	2022-02-14
2021-09-30	$12,840,000	500,000	0.0%	Shares	Sole	2021-11-15
2021-06-30	$13,820,000	500,000	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.